UniQure cashes in $91,250,000 from the offering?

Dutch gene therapy company uniQure N.V. on wednesday announced the pricing of its underwritten public offering of 5,000,000 of its ordinary shares at a public offering price of $18.25 per share.

UniQure said it expects to get $91,250,000 from the offering.

The company added that all ordinary shares to be sold in the offering are being sold by uniQure.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.